| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/23/2000 | WO2000028020A3 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 11/23/2000 | WO2000028013A3 Gene expression modulated by activation of microglia or macrophages |
| 11/23/2000 | WO2000027994A3 Chlamydia pneumoniae genome sequence |
| 11/23/2000 | WO2000027429A3 Vaccine against papillomatous digital dermatitis (pdd) |
| 11/23/2000 | WO2000027423A3 Methods and compositions for treating common cold symptoms |
| 11/23/2000 | WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 11/23/2000 | WO2000024938A3 CCG REPEATS IN cDNAs FROM HUMAN BRAIN |
| 11/23/2000 | WO2000023100A3 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 11/23/2000 | WO2000023053A3 Artificial antigen-specific cells and related methods |
| 11/23/2000 | WO2000022169A9 DETECTION USING Snz AND Sno GENES AND PROTEINS |
| 11/23/2000 | WO2000022093A3 Novel interferon stimulated and repressed genes |
| 11/23/2000 | WO2000020450A3 Calcium channel alpha-2/delta gene |
| 11/23/2000 | WO2000017369A3 Alzheimer's disease secretase |
| 11/23/2000 | WO2000016098A9 Composite devices incorporating biological material and methods |
| 11/23/2000 | WO2000015790A3 Leptin induced genes |
| 11/23/2000 | WO2000015666A3 Compositions and methods for the treatment of tumors |
| 11/23/2000 | WO2000009666A3 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 11/23/2000 | WO2000007545A3 Apoptosis proteins |
| 11/23/2000 | WO1999048482A3 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 11/23/2000 | WO1999004775A3 Method of treating dopaminergic and gaba-nergic disorders |
| 11/23/2000 | DE19923568A1 Incorporating gcpE and yfgB genes into viruses and cells, for increasing isoprenoid content and identifying e.g. antimicrobial agents, comprises using DNA sequences from bacteria or parasites |
| 11/23/2000 | DE19923168A1 Neue Fluoreszenzfarbstoffe und ihre Verwendung als Fluoreszenzmarker New fluorescent dyes and their use as fluorescent markers |
| 11/23/2000 | DE19919982A1 Verfahren zur Ermittlung osteoporotischer Prozesse Procedure for the determination of osteoporotic processes |
| 11/23/2000 | DE19919634A1 Test zur Bestimmung der Integrität komplexer Phospholipid/Lipid-Strukturen mit Hilfe synthetischer NBD-markierter Acylglyceride und dessen Anwendung zur Bestimmung der Aktivität von Lipasen Test to determine the integrity of complex phospholipid / lipid structures using synthetic NBD-labeled acylglycerides and its application to determination of the activity of lipases |
| 11/23/2000 | CA2376722A1 Chloramphenicol biosynthetic pathway and gene cluster characterization |
| 11/23/2000 | CA2374053A1 Secreted polypeptides and corresponding polynucleotides |
| 11/23/2000 | CA2373231A1 Extracellular signaling molecules |
| 11/23/2000 | CA2373191A1 Full-length molecules expressed in human tissues |
| 11/23/2000 | CA2372926A1 143 human secreted proteins |
| 11/23/2000 | CA2372851A1 Device and method for monitoring and controlling biologically active fluids |
| 11/23/2000 | CA2372783A1 Identifying material from a breast duct |
| 11/23/2000 | CA2372761A1 Methods for predicting and/or diagnosing the risk of gastric cancer |
| 11/23/2000 | CA2372667A1 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus |
| 11/23/2000 | CA2372661A1 Cdx2 is downstream mediator of apc tumor suppressor activity |
| 11/23/2000 | CA2372654A1 Acquired resistance genes in plants |
| 11/23/2000 | CA2372541A1 Sphingosine kinase enzyme |
| 11/23/2000 | CA2372485A1 Cell concentration and lysate clearance using paramagnetic particles |
| 11/23/2000 | CA2372294A1 Genetic marker for meat quality, growth, carcass and reproductive traits in livestock |
| 11/23/2000 | CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily |
| 11/23/2000 | CA2372102A1 Lawsonia derived gene and related omph polypeptides, peptides and proteins and their uses |
| 11/23/2000 | CA2372098A1 Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses |
| 11/23/2000 | CA2372095A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses |
| 11/23/2000 | CA2372036A1 Compositions of solvents and high concentrations of nucleic acid analogs |
| 11/23/2000 | CA2371245A1 Crystal structure of ribosomal protein l11/gtpase activating region rrna and uses thereof |
| 11/23/2000 | CA2371212A1 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 11/23/2000 | CA2369376A1 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for prevention of cancer in at-risk subjects |
| 11/23/2000 | CA2368833A1 Molecules expressed in hippocampus |
| 11/23/2000 | CA2368624A1 Novel .beta.-secretase and modulation of .beta.-secretase activity |
| 11/22/2000 | EP1054259A1 Method for the identification of a target compound |
| 11/22/2000 | EP1054258A1 Homogeneous enzyme immunoassay process using second antibody |
| 11/22/2000 | EP1054066A2 Method for anticipating sensitivity to medicine for osteoporosis and a reagent therefor |
| 11/22/2000 | EP1054059A1 Novel cDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation |
| 11/22/2000 | EP1054056A1 Apparatus for immobilized dna library preparation, apparatus for gene amplification, method for temperature control and method for comparing genes systematically |
| 11/22/2000 | EP1054055A1 Method for providing a substrate structure for oriented neuron growth, substrate structure, and device for monitoring neurons |
| 11/22/2000 | EP1054039A1 Fluorescent dyes and their use as fluorescent labelling agents |
| 11/22/2000 | EP1053474A1 Method for the determination of prosthetic infections |
| 11/22/2000 | EP1053460A2 An automatic method of classifying molecules |
| 11/22/2000 | EP1053357A1 Processes for isolating, amplifying and characterizing dna |
| 11/22/2000 | EP1053356A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
| 11/22/2000 | EP1053355A2 Pna and dna conjugates and methods for preparation thereof |
| 11/22/2000 | EP1053354A1 Direct detection of rna mediated by reverse transcriptase lacking rnase h function |
| 11/22/2000 | EP1053353A1 Eluting reagents, methods and kits for isolating dna |
| 11/22/2000 | EP1053352A1 Mismatch detection techniques |
| 11/22/2000 | EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 11/22/2000 | EP1053350A1 Methods for dna amplification and sequencing |
| 11/22/2000 | EP1053349A1 Methods for identifying therapeutic targets |
| 11/22/2000 | EP1053348A2 Determination of a genotype of an amplification product at multiple allelic sites |
| 11/22/2000 | EP1053346A1 Biosensor for pentachlorophenol |
| 11/22/2000 | EP1053345A1 Method for producing baccatin |
| 11/22/2000 | EP1053343A2 Targeting of genetic vaccine vectors |
| 11/22/2000 | EP1053335A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 11/22/2000 | EP1053334A1 Plant alkaline and neutral invertases |
| 11/22/2000 | EP1053332A1 Protein |
| 11/22/2000 | EP1053324A1 Novel cystine knot protein and materials and methods for making it |
| 11/22/2000 | EP1053323A2 Human receptor proteins |
| 11/22/2000 | EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 11/22/2000 | EP1053320A2 Human transport-associated molecules |
| 11/22/2000 | EP1053319A2 Human genes and gene expression products ii |
| 11/22/2000 | EP1053318A2 Cdnas encoding secreted proteins |
| 11/22/2000 | EP1053317A1 Use of ribozymes for functionating genes |
| 11/22/2000 | EP1053313A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences |
| 11/22/2000 | EP1053312A2 Optimization of immunomodulatory properties of genetic vaccines |
| 11/22/2000 | EP1053311A2 Compositions and methods for using a lysing matrix for isolating dna |
| 11/22/2000 | EP1053309A1 Compositions and methods for wound healing |
| 11/22/2000 | EP1053308A1 Dendritic enriched secreted lymphocyte activation molecule |
| 11/22/2000 | EP1053306A1 Secreted proteins and polynucleotides encoding them |
| 11/22/2000 | EP1053305A1 SUBSTRATE ANALOGS FOR MurG, METHODS OF MAKING SAME AND ASSAYS USING SAME |
| 11/22/2000 | EP1053298A1 Integrated microfluidic devices |
| 11/22/2000 | EP1053249A2 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production |
| 11/22/2000 | EP1053245A1 45 human secreted proteins |
| 11/22/2000 | EP1053237A2 Inhibition of human telomerase by a g-quadruplex-interaction compound |
| 11/22/2000 | EP1053055A1 Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis |
| 11/22/2000 | EP1053007A2 Methods and compositions for modulating leptin activity |
| 11/22/2000 | EP1045923A4 Method for isolation and identification of (escherichia coli) 0157:h7 and plating media for said process |
| 11/22/2000 | EP1008098A4 Method for remote sensing analysis by decorrelation statistical analysis and hardware therefor |
| 11/22/2000 | EP0765476B1 The use of sialic acid determination for determining alcohol consumption |
| 11/22/2000 | CN2407012Y Disposable box for testing escherichia coli |
| 11/22/2000 | CN1274421A Biosensor |
| 11/22/2000 | CN1274389A Methods for DNA amplification and kits therefor |
| 11/22/2000 | CN1274386A Genetic control of plant growth and develepmnt |